| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/25/2009 | EP2027112A2 Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof |
| 02/25/2009 | EP2027111A2 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts |
| 02/25/2009 | EP2027110A2 Mglur5 modulators iii |
| 02/25/2009 | EP2027091A1 New pharmaceutical compounds |
| 02/25/2009 | EP2026831A2 Methods and compositions for treating and preventing peripheral nerve damage |
| 02/25/2009 | EP2026819A1 Prevention and/or treatment of neurodegenerative disorders |
| 02/25/2009 | EP2026814A2 Mirtazapine for the treatment of neuropathic pain |
| 02/25/2009 | EP2026812A1 Use of 1,7-dimethylxanthine for the manufacture of a non-anxiogenic psychoanaleptic drug for the treatment of a neuropsychiatric disorder |
| 02/25/2009 | EP2026804A1 Ibudilast for inhibiting macrophage migration inhibitory factor (mif) activity |
| 02/25/2009 | EP2026803A2 Compositions of r(+) and s(-) pramipexole and methods of using the same |
| 02/25/2009 | EP2026793A2 Use of escitalopram for improving cognition |
| 02/25/2009 | EP2026792A2 Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia |
| 02/25/2009 | EP2026790A2 Co-therapy for the treatment of epilepsy and related disorders |
| 02/25/2009 | EP2026783A2 Method for enhancing cognitive function |
| 02/25/2009 | EP1878732B1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR |
| 02/25/2009 | EP1836168B1 Benzoyl-tetrahydropyridine as glyt-1 inhibitors |
| 02/25/2009 | EP1716126B1 Morpholine derivatives as norepinephrine reuptake inhibitors |
| 02/25/2009 | EP1534675B1 Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo¬3.1.0 hexane derivatives as muscarinic receptor antagonists |
| 02/25/2009 | EP1530469B1 Transdermal dosage form comprising an active agent and a salt and free-base form of an antagonist |
| 02/25/2009 | EP1392270B1 Abuse resistant pharmaceutical composition containing capsaicin |
| 02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
| 02/25/2009 | CN101374863A Immunoglobulins directed against NOGO |
| 02/25/2009 | CN101374839A Azaindoles useful as inhibitors of janus kinases |
| 02/25/2009 | CN101374836A Muscarinic agonists and methods of use thereof |
| 02/25/2009 | CN101374833A Novel pyrone-indole derivatives and process for their preparation |
| 02/25/2009 | CN101374832A Use of 4-imidazole derivatives for CNS disorders |
| 02/25/2009 | CN101374826A Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 02/25/2009 | CN101374814A Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |
| 02/25/2009 | CN101374529A Method of stabilizing s-adenosyl-l-methionine and stabilized composition |
| 02/25/2009 | CN101374525A Memantine for the treatment of childhood behavioral disorders |
| 02/25/2009 | CN101374519A Modulators of muscarinic receptors |
| 02/25/2009 | CN101374518A Novel histidine derivative |
| 02/25/2009 | CN101374517A Use of 2-imidazoles for the treatment of CNS disorders |
| 02/25/2009 | CN101374516A Use of substituted 2-imidazole of imidazoline derivatives |
| 02/25/2009 | CN101374514A Neuronal nicotinic receptor ligands and their use |
| 02/25/2009 | CN101374513A Use of benzo-fused heterocycle sulfamide derivatives for the treatment of epilepsy |
| 02/25/2009 | CN101374512A Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
| 02/25/2009 | CN101372511A Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 02/25/2009 | CN101372507A Signal conotoxin mutant polypeptides compound lt14a-7, preparation and use thereof |
| 02/25/2009 | CN101372474A 2-(1h-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| 02/25/2009 | CN101371903A Orally taken Chinese medicinal composition for treating angioneurotic headache |
| 02/25/2009 | CN101371888A Red date powder for good sleep |
| 02/25/2009 | CN101371885A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371884A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371883A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371874A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371873A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371872A Method for producing hard capsule using Acanthopanax senticosus and schisandra chinensis |
| 02/25/2009 | CN101371867A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371866A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371865A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
| 02/25/2009 | CN101371863A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371862A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371860A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371859A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371858A Patrinia scaniosaefolia extract as well as preparation method and application thereof |
| 02/25/2009 | CN101371843A Use of loxapine and amoxapine for the perparation of a medicament for the treatment of pain |
| 02/25/2009 | CN101371836A Paroxetine enteric sustained-release composition |
| 02/25/2009 | CN101371832A Medical use of triacetyl andrographolide as proinflammatory cytokine inhibitor |
| 02/25/2009 | CN101371830A Medicament for inhibiting endothelial cell of cerebral vessels to secrete prostaglandin E2 |
| 02/25/2009 | CN101371827A Resveratrol composition for delaying age |
| 02/25/2009 | CN101371826A Percutaneous absorption patch |
| 02/25/2009 | CN101371713A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371712A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371711A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371710A Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof |
| 02/25/2009 | CN100463908C Substituted 8' -pyridinyl-dihydrospiro- [cycloalkyl] -pyrimido [1,2-a] pyrimidin-6-one and 8' -pyrimidinyl-dihydrospiro- [cycloalky]l -pyrimido p1,2-a] pyrimidin-6-one derivatives |
| 02/25/2009 | CN100463704C Integrated medicament conveying system |
| 02/25/2009 | CN100463676C Control releasing venlafaxine hydrochloride tablet and its preparation |
| 02/25/2009 | CN100463611C Processing method of natural bamboo juice soy sauce |
| 02/24/2009 | US7495127 Calcium-activated potassium channel (BK channel) with opening activity equivalent to or higher than that of maxikdiol, and has high specificity; pimaric acid, dihydropimaric acid, dihydroisopimarinol, sandaracopimaric acid, isopimaric acid, and dihydroisopimaric acid |
| 02/24/2009 | US7495109 Nociceptin analogs |
| 02/24/2009 | US7495020 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 02/24/2009 | US7495018 An enzyme inhibitor of p38 MAP kinase, an antagonist of tumor necrosis factors or adenosine receptor, a thiazole with the 5-pyridyl group derivatives |
| 02/24/2009 | US7495017 3-(3-Cyclopentyloxy-4-methoxyphenyl)-1H-pyrazole;adenosine monophosphate activator; antiinflammatory agent, antidepressant, antiallergen, cognition activator, neurodegenerative diseases; arthritis, Alzheimer's disease, schizophrenia, Parkinson disease |
| 02/24/2009 | US7495009 Imidazopyridine derivatives as melancortin receptor agonists |
| 02/24/2009 | US7494989 Pyridine compounds useful as N-type calcium channel antagonists |
| 02/24/2009 | US7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 02/24/2009 | US7494655 antigenic peptides, antibodies and carriers, diluents, excipients, adjuvants or auxiliary agents, use for inhibiting the formation of beta-amyloid; treatment of Alzheimer's disease or Down's syndrome |
| 02/24/2009 | US7494645 proteins comprising an amino acid sequence including the catalytic region and regulatory domains; the protein inhibits neurite retraction in an (lysophosphatidic acid) LPA-induced neurite retraction bioassay; used for treating nervous system disorders and/or injuries |
| 02/24/2009 | CA2471338C Use of deoxypeganine for treating clinical depression |
| 02/24/2009 | CA2469813C Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 02/24/2009 | CA2468370C Chronic, bolus administration of d-threo methylphenidate |
| 02/24/2009 | CA2432085C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 02/24/2009 | CA2426221C New neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds |
| 02/24/2009 | CA2417361C New phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines |
| 02/24/2009 | CA2390563C Apparatus and method for preparing microparticles using in-line solvent extraction |
| 02/24/2009 | CA2356151C Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 02/24/2009 | CA2339913C Pharmaceutical formulations and method for making |
| 02/24/2009 | CA2334919C Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects |
| 02/24/2009 | CA2316972C Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 02/24/2009 | CA2264238C Galenic formula with extended release of milnacipran |
| 02/24/2009 | CA2262582C Hcg and derivatives as matrix metalloproteases inhibitors |
| 02/24/2009 | CA2225416C A triazolylmethyl-indole ethylamine bisulfate salt |
| 02/24/2009 | CA2219455C Use of pyrrolidine derivatives for treating alcoholism |
| 02/24/2009 | CA2179029C Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 02/19/2009 | WO2009023844A2 3' substituted compounds having 5-ht6 receptor affinity |
| 02/19/2009 | WO2009023757A1 Therapeutic compounds |
| 02/19/2009 | WO2009023677A1 Derivatives of 5-amino-4, 6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
| 02/19/2009 | WO2009023453A1 Azepine derivatives as gamma-secretase inhibitors |